Long-term benefit of rituximab in MuSK autoantibody myasthenia gravis patients: Table 1

Rituximab in refractory and non-refractory myasthenia: A retrospective multicenter study

(2012) Nicolas Collongues et al.   MUSCLE & NERVE

Long-lasting treatment effect of rituximab in MuSK myasthenia

(2012) J. Diaz-Manera et al.   NEUROLOGY

Response of patients with refractory myasthenia gravis to rituximab: a retrospective study

(2011) Richard J. Nowak et al.   Therapeutic Advances in Neurological Disorders

The use of rituximab in myasthenia gravis and Lambert-Eaton myasthenic syndrome

(2010) P. Maddison et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project

(2009) K. R. Carson et al.   BLOOD

Clinical Phenotype of Muscle-specific Tyrosine Kinase-antibody-positive Myasthenia Gravis

(2008) Gil I. Wolfe et al.   Annals of the New York Academy of Sciences

Successful treatment of refractory generalized myasthenia gravis with rituximab

(2008) C. Lebrun et al.   EUROPEAN JOURNAL OF NEUROLOGY

Sustained response to Rituximab in anti-AChR and anti-MuSK positive Myasthenia Gravis patients

(2008) Isabel Illa et al.   JOURNAL OF NEUROIMMUNOLOGY